Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer

Study ID
NCT00984048

Study type
Observational

Study phase

Study status
Completed

Trial Acronym

Trial Summary

This is a multicenter translational study to understand therapeutic resistance in patients undergoing first-line chemotherapy (FOLFOX/Avastin, or FOLFIRI/Avastin) for metastatic colorectal cancer. Tissue samples from liver metastasis will be collected and banked before the start of chemotherapy and at the time of progression. Additionally, blood samples will be drawn monthly and stored in the tissue biobank.

More informations

Trial Starting Date

Aug 31,2009

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

160